AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
The Department of Homeland Security (DHS) continues to review proposals from companies hoping to deliver a new-generation of bio-detection capabilities under the BioWatch program and expects now to award one or more contracts in November for additional development and field testing, a DHS official tells TR2.
The contracts will be for the Gen-3 portion of BioWatch and will permit DHS' Office of Health Affairs to conduct component, subsystem and system level testing.
DHS had hoped to make awards this month at the latest but decided that given the complexities of the Gen-3 systems warranted further discussions with the hopeful suppliers.
"We needed to have further discussions with industry to make sure that it's clear to them what we're asking and it's also clear to us what they're able to provide so we can make the best decision for the government," the official says.
Under Gen-3 companies--some …